A new kind of flu vaccine has moved a step closer to the U.S. market as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the COVID-19 ...
Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly skin cancer melanoma ...
WASHINGTON – The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday. The ...
Researchers reviewed laboratory, clinical, and real-world data on mRNA vaccines. They confirmed safety and effectiveness and ...
U.S. health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic.Video above: These are the three major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results